tradingkey.logo
tradingkey.logo
Pesquisar

Stereotaxis Inc

STXS
Adicionar à lista de desejos
1.790USD
+0.020+1.13%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
174.50MValor de mercado
PerdaP/L TTM

Mais detalhes de Stereotaxis Inc Empresa

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Informações de Stereotaxis Inc

Código da empresaSTXS
Nome da EmpresaStereotaxis Inc
Data de listagemAug 12, 2004
CEOFischel (David Leo)
Número de funcionários139
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 12
Endereço710 N Tucker Blvd
CidadeST. LOUIS
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal63101
Telefone13146786100
Sitehttps://www.stereotaxis.com/
Código da empresaSTXS
Data de listagemAug 12, 2004
CEOFischel (David Leo)

Executivos da empresa Stereotaxis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Stereotaxis Inc?

Os cinco principais acionistas de Stereotaxis Inc são: Mr. David W. Benfer

Quantas instituições possuem ações da Stereotaxis Inc (STXS)?

Em 2026Q1, 205 instituições possuíam ações da Stereotaxis Inc, com valor de mercado aproximado de 49.70M, representando 50.99% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 2238158.00.